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Chitinases are enzymes that cleave chitin, a component of the
exoskeleton of many organisms including the house dust mite
(HDM). Here we show that knockin mice expressing an enzymat-
ically inactive acidic mammalian chitinase (AMCase), the dominant
true chitinase in mouse lung, showed enhanced type 2 immune
responses to inhaled HDM. We found that uncleaved chitin pro-
moted the release of IL-33, whereas cleaved chitin could be phago-
cytosed and could induce the activation of caspase-1 and subsequent
activation of caspase-7; this results in the resolution of type 2 immune
responses, probably by promoting the inactivation of IL-33. These
data suggest that AMCase is a crucial regulator of type 2 immune
responses to inhaled chitin-containing aeroallergens.
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Allergic asthma, affecting millions of people worldwide, is adisease characterized by chronic airway inflammation (1–3).
It is well established that immune responses to inhaled allergens
like house dust mite (HDM), cockroach, and animal dander provide
much of the underlying basis of asthma pathogenesis such as eo-
sinophilic inflammation of the airway, goblet cell metaplasia, and
bronchial hyperreactivity (1–5). HDM is one of the commonest
allergens, and up to 85% of asthmatics are known to be typically
HDM-allergic (1). The allergic potential of HDM relies on the
mites themselves and their fecal pellets (1).
Chitin, a long chain polymer of an N-acetylglucosamine, is the
second most abundant polysaccharide in nature after cellulose
(6, 7). It functions as a major structural polymer in many lower
life forms including the cell walls of bacteria and fungi, the shell
of crabs and shrimp, the exoskeleton of HDM and cockroaches,
and the microfilarial sheath of parasitic nematodes (6, 7). It is
not expressed by mammals (6, 7). Several lines of evidence in-
dicate that chitin can act as an immune stimulator (7). First, it
has been reported that i.v. administration of size-fractionated
(i.e., small) chitin particles induced the production of in-
terleukin-12 (IL-12), TNFα, and IL-18 from macrophages and
the production of IFN-γ from natural killer cells (components
common to a Th1-type response) (7, 8). In addition, it has been
demonstrated that chitin could inhibit type 2 immunity including
IgE production and eosinophilia (7, 9). Similarly, it has been
demonstrated that intranasal administration of chitin micropar-
ticles down-regulated allergic hypersensitivity to HDM (7, 10).
However, in contrast to the above-mentioned studies, it has been
reported that intranasal administration of chitin beads into mice
induced the accumulation of IL-4–expressing innate immune
cells including eosinophils and basophils and also induced al-
ternatively activated macrophages (11). Thus, chitin obviously
plays a role as a stimulator and/or a regulator of immune responses
although the exact role of chitin is controversial.
Chitinases are enzymes that degrade chitin and are made both
by organisms that express chitin, including parasites, and by the
hosts that harbor these organisms (7). Mammals, including hu-
mans, do not synthesize chitin but all mammals studied encode
chitinases (7). Among the several chitinases, there are only two
true chitinases having chitolytic enzyme activity that breaks down
glycosidic bonds of chitin in humans and mice; these are chito-
triosidase and acidic mammalian chitinase (AMCase) (7). Al-
though chitotriosidase is expressed in both humans and mice, it is
expressed at low levels in mouse lung, and thus AMCase is be-
lieved to be the dominant true chitinase in mouse lung (12–14).
Expression of AMCase has been shown to be increased in human
asthma patients and is also induced in mice in an aeroallergen
asthma model (15). In nonchitin-dependent asthma models such
as the ovalbumin-induced asthma model and IL-13–overexpressing
transgenic mice (15), blocking of AMCase by neutralizing antibody
ameliorated type 2 inflammation and airway hyperreactiveness.
However, in the chitin-beads model described above, chitin beads
pretreated with recombinant AMCase failed to induce type 2 im-
mune responses, and also chitin beads did not induce immune
responses in AMCase–overexpressing transgenic mice (11).
Chitinase-related proteins, other than chitotriosidase and
AMCase in humans and mice, can bind chitin but lack chitinase
activity as a result of mutations in the otherwise highly conserved
putative enzyme active sites; they are therefore called chitinase-
like proteins (CLPs) (7, 16). Breast regression protein 39 (BRP-
39) and its human homolog YKL-40 are CLPs induced in the
aeroallergen asthma mouse model and human asthma patients,
respectively (7, 17). In KO mice in which BRP-39 was deleted,
type 2 immune responses were diminished in the OVA-
induced mouse model or IL-13–overexpressing transgenic mice,
but the immune responses were rescued by crossing with an
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YKL-40–overexpressing transgenic mouse (17). However, the roles
in immune responses of many other CLPs are still largely unknown.
Taken together, despite a number of reports demonstrating
a crucial role of chitin and chitinase (and CLPs) in immune
responses, their exact function seems to be controversial. More
specifically, a clear distinction of the functional roles of merely
binding chitin as mediated by the CLPs versus cleaving chitin
as performed by chitotriosidase and AMCase has not been
achieved. Moreover, most studies have been done in a chitin-
independent aeroallergen mouse model such as the OVA-induced
model or IL-13–overexpressing transgenic mice. In our present
study, we generated enzymatically deficient AMCase knockin
(AMCase-ED) mice, which consequently resulted in the expres-
sion of inactive chitinase that is still able to bind to chitin. After
intranasal administration of HDM extracts into mice, we found
that AMCase-ED mice showed enhanced type 2 immune re-
sponses. Unlike cleaved chitin, the chitin that was not cleaved by
enzymatic dead AMCase in the lung failed to be phagocytosed,
which led to accumulation of IL-33, and thus prolonged exposure
of the lungs to this cytokine concomitantly enhanced type 2
immune responses. In contrast, in the wild-type mice, the chitin
that was adequately cleaved by active AMCase was phagocy-
tosed, which led to cleavage and inactivation of IL-33 and res-
olution of type 2 immune responses via caspase-1 and caspase-7
cascades.
Results
AMCase-ED Mice Show Enhanced Type 2 Immune Responses to
Inhaled HDM. To investigate the function of enzymatic activity
of AMCase in airway inflammation, we made an enzymatically
defective AMCase-ED mouse by replacing the aspartic acid with
alanine in the catalytic domain of AMCase (Fig. 1A and Fig. S1).
It has been previously shown, by transfecting the designed con-
struct into a cell line and measuring chitinase activity, that this
mutation of AMCase rendered the enzyme inactive without af-
fecting the binding of AMCase to chitin (18). These mice have
no overt developmental or phenotypic defects and are born at
normal Mendelian ratios. To induce type 2 immune responses,
we decided to use HDM because, as one of the common aller-
gens, HDM is a very pathologically relevant agent (1). First, we
wanted to determine the levels of chitin in HDM (Greer Labo-
ratories). Although it is clear that HDM contains chitin, the
commercial preparations widely used in many previous HDM
studies were prepared as extracts after filtration, suggesting that
larger fragments of chitin may have been removed. We com-
pared purified chitin with the purchased HDM and confirmed
that all batches of HDM used in this study contained chitin (Fig.
S2A). We then treated wild-type mice intranasally with HDM
and unfiltered raw HDM that contains larger fragments of chitin
(Greer Laboratories). We counted total cell number in the
bronchoalveolar lavage, which was increased following adminis-
tration of HDM compared with administration of control PBS
(Fig. 1B and Fig. S2B). Interestingly, AMCase-ED mice showed a
greater increase in cell number, consisting mostly of eosinophils
in the BAL after HDM administration. Similarly, raw HDM
treatment induced a greater increase in cell number compared
with HDM treatment, suggesting that the amount of chitin or the
size of the chitin plays a major role in cellular infiltration in the
BAL. However, after administration of raw HDM, AMCase-ED
mice did not show clear differences compared with control mice
as much as after administration of HDM, suggesting that in-
creased amounts of the larger fragments of chitin in raw HDM
may lead to accumulation of excessive levels of substrate that
WT mice cannot cleave and therefore result in the lack of sig-
nificant differences between WT and AMCase-ED mice. Heat
treatment of either HDM or raw HDM did not significantly af-
fect lung infiltrates, although HDM heat treatment showed a
reduced trend, implying the roles of heat-insensitive chitin and
other carbohydrates. There were no significant differences in
other cell types (Fig. S2B). We decided to use commercially
prepared filtered HDM (hereafter referred to as HDM) for
most experiments. Next we checked the expression of AMCase
in lung (Fig. S2C). Mice that were administrated HDM showed
elevated expression of AMCase compared to PBS-treated
control mice, but there was no difference in AMCase ex-
pression between WT mice and AMCase-ED mice after HDM
administration. However, although chitinase activity was also
elevated after HDM administration compared with PBS-trea-
ted control mice, there was no elevation of chitinase activity in
AMCase-ED mice, confirming that AMCase-ED mice lack most
chitinase activity and that AMCase is a major contributor to the
chitinase activity in this tissue under these conditions (Fig. S2D).
The expression of other CLPs such as Brp39, Ym1, and Ym2 was
also increased after HDM administration (Fig. S2E), but the
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Fig. 1. Enhanced type 2 immune responses to inhaled HDM in AMCase-ED
mice. (A) The schematic domains of AMCase. Aspartic acid is replaced with
alanine in active site of catalytic domain of AMCase in AMCase-ED mice.
(B) The number of total cells (Left) or eosinophils (Right) in the BAL of WT or
AMCase-ED mice after administration of PBS, HDM, or raw HDM with (+)
or without (−) pretreatment at 95 °C for 10 min. (C) H&E staining of lung
sections of WT or AMCase-ED mice after administration of PBS or HDM
(magnification: 20x). (D) The production of IL-5 (Left) and IL-13 (Right). The
cells of lung-draining lymph nodes from WT or AMCase-ED mice after ad-
ministration of PBS or HDM were restimulated in vitro with HDM and
mitomycin-C–treated splenocytes for 48 h. Supernatants were collected and
analyzed for IL-5 and IL-13 by ELISA. (E) The level of IgE in serum of WT or
AMCase-ED mice after administration of PBS or HDM. The serum was di-
luted with PBS sequentially and analyzed for IgE by ELISA. (F ) The ex-
pression of ccl11, ear11, and muc5b, normalized to hypoxanthine-guanine
phosphoribosyltransferase, in the lung of WT or AMCase-ED mice after
administration of PBS or HDM. *P < 0.05, **P < 0.01, and ***P < 0.001,
unpaired Student’s t test. Data were combined from at least four independent
experiments. Error bars indicate the SEM.
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expression of chitotriosidase, which is the only other active chiti-
nase, was not detected even after HDM administration. Histologic
examination also showed more severe inflammation in AMCase-ED
mice after HDM administration (Fig. 1C). To measure the ex-
pression of IL-5 and IL-13, T cells were collected from draining
lymph nodes and then restimulated with HDM. T cells from
HDM-administered AMCase-ED mice showed more IL-5 and
IL-13 production compared with T cells from HDM-administrated
control mice (Fig. 1D). Total serum IgE levels and also HDM-
specific IgE levels were higher in HDM-administrated AMCase-ED
mice (Fig. 1E and Fig. S2F), and, finally, the expression of the
chemokines ccl11 and ear11 and the mucin gene muc5b was also
increased in the lung from HDM-administrated AMCase-ED
mice (Fig. 1F). Altogether, these results indicated that there
is a greater type 2 immune response in AMCase-ED mice
in response to inhaled HDM than in mice with intact
AMCase activity.
Uncleaved Chitin Promotes Stronger Type 2 Immune Responses. To
check whether the enhanced immune response to inhaled HDM
in AMCase-ED mice is due to chitin and also due to the lack of
chitinase activity in AMCase-ED mice, we directly administered
chitin intranasally to these mice. For this study, we fractionated
purified chitin by size and then separated the chitin into three
size bins: small (less than 40 μm), intermediate (40–70 μm), and
large (70–100 μm) chitin (Fig. 2A). We found that the expression
of AMCase transcript was increased in mice that received small
chitin compared to PBS-treated control mice (Fig. 2B). Large
chitin-treated mice showed still greater expression of AMCase
compared with small chitin-administrated mice. Other CLPs
such as Brp39, Ym1, and Ym2 were also induced after chitin
administration and expressed at higher levels after administra-
tion of large chitin rather than small chitin (Fig. S3A). There was
no difference in AMCase expression between WT and AMCase-ED
mice after small- or large-chitin administration (Fig. 2B). Infiltration
of immune cells into the lungs was greater upon administration of
large versus small chitin to mice, and the majority of cells that were
increased were eosinophils (Fig. 2C). Histologic analysis also
showed more severe inflammation following administration of
large rather than small chitin (Fig. 2D). AMCase-ED mice showed
greater cellular infiltration in the BAL compared with WT mice
upon administration of either small or large chitin (Fig. 2E and Fig.
S3B). The expression levels of ccl11, ear11 and muc5b was greater
following administration of large chitin versus small chitin and their
expression was also induced to a higher level in AMCase-ED mice
comparing to WT mice (Fig. 2F). We therefore concluded that
chitin itself could elicit pulmonary inflammation and that uncleaved
chitin causes a stronger response than cleaved chitin. Moreover, we
observed that the responses of AMCase-ED mice were stronger in
all parameters measured, probably due to a failure to cleave chitin.
Chitin Uncleaved by Enzymatically Dead AMCase Is Not Phagocytosed
and Fails to Activate Caspase-1. Chitosan, a commercially available
deacetylated chitin, but not chitin, has been reported to activate
caspase-1 by the phagocytic pathway (19). It has also been shown
that the size of chitosan was important for phagocytosis (19, 20).
In fact, the differential role of the size of chitin was supported by
another report (21). In our system, chitosan indeed seemed to
induce more IL-1β production than chitin in vitro, probably due
to the easier accessibility of chitosan to the cells, which might
derive from the different solubility between chitin and chitosan,
but chitin itself also significantly induced IL-1β (Fig. S4A and
Fig. 3C). As chitin is the second most abundant polysaccharide in
nature and a true component of the exoskeleton of HDM (1, 7),
we reasoned that chitin would be a more physiologically relevant
inducer, and thus we decided to use chitin in our experiments to
examine the role of the enzymatic activity of AMCase. Although
we purified the chitin to reduce endotoxin, we still could not
exclude the possibility of contamination of these preparations
with small amounts of endotoxin or other contaminants (Fig.
S4B). To focus on the effect of chitin and eliminate the potent
effects of contaminating endotoxin, we pretreated the macro-
phages with LPS, so that incremental effects of small amounts of
LPS derived from the chitin would be negligible, and actually we
did not see a significant difference between priming with and
without LPS. First, we took peritoneal macrophages from WT
and AMCase-ED mice, as AMCase is secreted from both mac-
rophages and lung epithelial cells. Peritoneal macrophages were
treated with a chitin mixture (less than 70 μm) and then assayed
for chitinase activity (Fig. 3A). We found that chitinase activity
was induced, peaked at 2 h after chitin treatment, and was sus-
tained for 4 h. Chitin-treated macrophages showed caspase-1
activation in a dose-dependent manner, whereas, interestingly,
caspase-1 activation in the macrophages from AMCase-ED mice
was dramatically diminished (Fig. 3B). Again, we cannot ex-
clude the possibility that the residual endotoxin contamination
in our chitin preparation favors caspase-1 activation. Regarding
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Fig. 2. The enhanced type 2 immune responses to inhaled chitin in AMCase-ED
mice. (A) The images of fractionated chitin. (B) The expression of AMCase,
normalized to HPRT, in the lung of WT or AMCase-ED mice after adminis-
tration of PBS, small-chitin, or large-chitin fragments. (C) The number of total
cells (Left) or eosinophils (Right) in the BAL of WT mice after administration
of PBS, small-chitin, or large-chitin fragments. (D) H&E staining of lung sec-
tions of WTmice after administration of small-chitin or large-chitin fragments
(magnification: 20x). (E) The number of total cells and eosinophils in the BAL
of WT mice after administration of small-chitin (Top) and large-chitin frag-
ments (Bottom). (F) The expression of ccl11, ear11, and muc5b, normalized to
HPRT in the lung of WT or AMCase-EDmice after administration of PBS, small-
chitin, or large-chitin fragments. *P < 0.05, **P < 0.01, and ***P < 0.001, un-
paired Student’s t test. Data were combined from at least three independent
experiments. Error bars indicate the SEM.
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the production of IL-1β and TNFα, their expression showed
dose- and time-dependent induction (Fig. S4A). As reported
previously (19), small chitin induced greater production of IL-1β
rather than intermediate or large chitin, and we also confirmed
that intermediate chitin fragmented by sonication could induce
IL-1β to a greater extent than untreated intermediate chitin (Fig.
3C). The production of IL-1β was reduced in cytochalasin D
pretreated macrophages, suggesting that IL-1β production by
chitin is dependent on phagocytosis as described in a previous
report (19). Interestingly, the production of IL-1β was reduced in
macrophages from AMCase-ED mice upon the treatment of all
sizes of chitin fragments whereas the production of TNFα was
unaltered (Fig. 3D). To further investigate whether the reduced
production of IL-1β from AMCase-ED macrophages is due to a
defect in phagocytosis, we labeled small chitin with FITC and
then analyzed the cells by flow cytometry (Fig. 3E). The mac-
rophages fromWTmice took up FITC-labeled chitin to a greater
extent than the macrophages from AMCase-ED mice, but their
ability to phagocytose similar amounts of FITC-labeled latex
beads suggests that the deficient chitin uptake in macrophages
from AMCase-ED mice was due to the inability to cleave chitin
because of the enzymatically dead AMCase, rather than due to
a fundamental problem with phagocytosis itself. We also con-
firmed that the phagocytic efficiency was dependent on the
amounts of active AMCase from WT macrophages as, when we
mixed the cells from WT and AMCase-ED mice, the WT enzyme
complemented the deficiency in the AMCase-ED cells (Fig. 3F).
Moreover, we found that phagocytosis of chitin was blocked by
AMCase inhibitor (bisdionin F) (Fig. S4C). Taken together, we
concluded that cleaved chitin was phagocytosed, leading to the
activation of caspase-1 and the production of IL-1β, whereas
uncleaved chitin was not phagocytosed and was associated with
reduced activation of both caspase-1 and the production of IL-1β.
Casp1−/− Mice Show Enhanced Type 2 Immune Responses After HDM
Treatment. The above-mentioned results predicted a role for
caspase-1 in the airway response to chitin, and thus for HDM.
We therefore examined the immune responses of Casp1−/− mice
after HDM administration. Casp1−/− mice showed a greater cell
infiltration in the BAL, and the majority of the increased cells
were eosinophils (Fig. 4A and Fig. S5A). Histologic analysis also
revealed greater inflammation in Casp1−/− mice (Fig. 4B), and
the levels of both IL-5 and IL-13 from T cells from draining
lymph nodes of Casp1−/− mice were elevated compared with
wild-type mice when we restimulated them with HDM (Fig. 4C).
Moreover, both total IgE levels and HDM-specific IgE levels
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Fig. 3. Defective caspase-1 activation after administration of chitin in AMCase-ED cells. (A) Chitinase activity in the supernatants of LPS-primed peritoneal
macrophages from WT or AMCase-ED mice after chitin mixture (less than 70 μm) treatments. (B) Immunoblot analysis of caspase-1 and β-actin in LPS-primed
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termediate-, or large-chitin fragments with (+) or without (−) sonication. (E) Histograms of fluorescence distribution of the peritoneal macrophages from WT
(blue) or AMCase-ED mice (green) after FITC-conjugated small-chitin (Left) or latex bead (Right) treatment. Red represents WT cells without any treatment.
(F) Histograms of fluorescence distribution of the mixture of peritoneal macrophages from WT and AMCase-ED mice. Yellow represents 100% of WT cells,
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treatment. Data are representative of at least three independent experiments. Error bars indicate the SD.
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were indeed higher in Casp1−/− mice (Fig. 4D and Fig. S5B), and
ccl11, ear11, and muc5b were expressed at a higher level in the
lungs of Casp1−/− mice (Fig. 4E). These results are in contrast
to previous reports showing less inflammation in Casp1−/− mice
after OVA administration (22) and increased levels of IL-1β in
asthma patients (23–25). However, the OVA model is chitin-
independent so we inferred that chitin was a key difference that
contributed to the different response seen in Casp1−/− mice after
HDM administration. In addition, this does not appear to be an
IL-1 effect, as IL-1 receptor (Il1r−/−)–deficient mice also did not
show any difference in cell infiltrates and particularly not in
eosinophil counts after HDM administration in our HDM model
(Fig. S6A). Furthermore, AMCase-ED mice also showed no
difference to wild-type mice in airway inflammation and the
production of IL-5 and IL-13 in the adjuvant-dependent i.p.
sensitization OVA–Alum model, suggesting that the increased
type 2 immune responses in AMCase-ED mice after HDM ad-
ministration are highly correlated to chitin itself and the enzy-
matic activity of AMCase (Fig. S6 B and C).
HDM Promotes Increased IL-33 Production in AMCase-ED and Casp1−/−
Mice. It is well known that HDM instructs a type 2 immune re-
sponse via the release of innate pro-Th2 cytokines including
TSLP, IL-25, and IL-33 (1, 3, 26). Indeed, a recent report that
showed that IL-33, but not TSLP or IL-25, is central to mite and
peanut allergic sensitization led us to focus on IL-33 (27).
Moreover, another report showed that IL-33−/− mice exhibited a
significantly diminished inflammatory cell influx into the BAL
fluid after HDM administration (28). Because AMCase is se-
creted by both epithelial cells and macrophages (15), we performed
bone marrow chimeras of WT and AMCase-ED mice (where
AMCase-ED or WT bone marrow was injected into irradiated
AMCase-ED or WT recipients) to distinguish the role of epi-
thelial cells and macrophages. Both WT → AMCase-ED and
AMCase-ED → WT chimeric mice showed greater airway in-
flammation compared with WT → WT mice but less in-
filtration compared with ED → ED mice, suggesting that both
epithelial cells and macrophages contribute biologically signifi-
cant amounts of AMCase (Fig. 5A and Fig. S7). As WT → ED
chimeric mice showed a somewhat greater increase in total cell
number and eosinophil number comparing to ED → WT chi-
meric mice, it is possible that epithelial cells may play a greater role
in secreting AMCase than macrophages although we cannot ex-
clude the possibility of the contribution of radio-resistant hema-
topoietic cells. As expected, control AMCase-ED → AMCase-ED
mice showed a greater cell infiltrate in the BAL comparing to
WT → WT chimeric mice, and again the majority of increased
cells were eosinophils. Moreover, ED→ ED mice secreted more
IL-33 in the BAL compared to WT →WT mice, which suggests
that the stronger type 2 immune responses were indeed corre-
lated with greater release of IL-33 in the BAL (Fig. 5B). Both
AMCase-ED mice and Casp1−/− mice indeed showed elevated
release of IL-33 in the BAL compared to WT mice (Fig. 5 C and
D). Interestingly, chitin itself promoted the release of IL-33 in
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the BAL. Although IL-33 was not detected when small chitin
was administrated, copious IL-33 was released in AMCase-ED
mice compared to WT mice upon large-chitin administration
(Fig. 5E). These results suggest that uncleaved chitin cannot be
phagocytosed into the cells and may reside outside the cells, which
may promote tissue damage and thus the release of IL-33 in the
lung. This in turn supports the concept that an important func-
tion of AMCase is to attenuate this response.
Activation of Caspase-7 Is Dependent on Caspase-1. It has been
reported that full-length IL-33 is biologically active (29–31) and
is processed into an inactive form by caspases such as caspase-7,
activated during apoptosis (30, 32). Similarly, it is also reported
that inflammasome-activated caspase-7 cleaves PARP1 to en-
hance the expression of a subset of NF-kappaB target genes, and,
in that study, caspase-7 activation was found to be dependent on
caspase-1 (33). Moreover, it was reported that caspase-7 acti-
vation by the Nlrc4 inflammasome restricts Legionella pneumo-
phila infection, and again caspase-7 activation was also shown to
be dependent on caspase-1 (34). We therefore hypothesized that
IL-33 is cleaved into its inactive form by caspase-7, which is acti-
vated by caspase-1, which itself is activated by HDM administration.
To address this model, we checked caspase-7 activation after HDM
administration. Interestingly, caspase-7 activation was abrogated in
the lungs of AMCase-ED mice (Fig. 5F) and almost absent from
Casp1−/− mice after HDM administration (Fig. 5G). Moreover, we
checked IL-33 cleavage in lung extracts. More cleaved IL-33 was
found inWTmice than in AMCase-EDmice (Fig. S8). These results
suggest that inefficient activation of caspase-1 or complete loss of
caspase-1 in mutant mice may cause failure of caspase-7 activation,
which in turn leads to prolonged exposure to active IL-33 and thus
enhanced type 2 immune responses.
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Casp7 −/−Mice Show More Type 2 Immune Responses to Inhaled HDM.
To address the prediction that type 2 immune responses should be
enhanced in the absence of caspase-7 activation, we administrated
HDM intranasally into Casp7−/− mice. The cell infiltrates in BAL
were significantly increased in Casp7−/− mice after HDM admin-
istration compared to WT mice, and the majority of the increased
cells were eosinophils (Fig. 6A and Fig. S9A). The production of
IL-5 and IL-13 from T cells from draining lymph nodes of
Casp7−/− mice was also higher than in WT mice when T cells
were restimulated with HDM (Fig. 6B). Total IgE and HDM-
specific IgE levels were again higher in Casp7−/− mice (Fig. 6C
and Fig. S9B), and the expression of ccl11, ear11, and muc5b was
also increased in the lung of Casp7−/− mice (Fig. 6D). Histologic
analysis showed more inflammation in Casp7−/− mice as well
(Fig. 6E), and, finally, the secretion of IL-33 in the BAL was
significantly higher in Casp7−/− mice compared to WT control
mice after HDM administration (Fig. 6F). Taken together, all
data suggest that the enhanced type 2 immune responses seen in
Casp7−/− mice result from the failure to inactivate IL-33 effec-
tively in the lung.
Discussion
In this study, we found that the enzymatic activity of AMCase
negatively regulates type 2 immune responses to allergens con-
taining chitin. The results support the following model. The enzy-
matically cleaved chitin is taken up by cells through phagocytosis,
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which then triggers activation of caspase-1 through this well-
characterized pathway (35, 36), whereas uncleaved chitin promotes
the release of IL-33 probably due to mechanical damage to lung
tissue. The activation of caspase-1 leads in turn to the activation of
caspase-7, which inactivates IL-33, thereby resolving type 2 immune
responses (Fig. S10).
In the absence of the enzymatic activity of AMCase, we found
that (i) chitin could not be cleaved or phagocytosed; (ii) chitin
could not activate caspase-1 and subsequently caspase-7, which
(iii) led to prolonged exposure of active IL-33 and (iv) sustained
type 2 immune responses.
It is interesting that chitins of different sizes have different
effects both in vivo and in vitro (19, 21). It was previously
reported that intranasal administration of chitin beads induced
infiltration of IL-4–expressing cells in lung, but administration of
chitin beads that were pretreated with recombinant AMCase
failed to induce infiltration of IL-4–expressing cells in lung (11).
It was also reported that mice that expressed AMCase consti-
tutively in lung demonstrated a significant reduction of eosino-
phil infiltration after administration of chitin beads or fungal
challenge (11, 35). These reports support our observations that
enzymatically inactive AMCase-ED mice showed enhanced in-
filtration of eosinophils in lung and type 2 immune responses
after administration of HDM or chitin. It is interesting that small
chitin (less than 40 μm) induced IL-10 production in vitro and in
vivo (21), suggesting that cleaved chitin may play an inhibitory
role in inflammatory responses. However, production of IL-10
by small chitin was increased in cytochalasin D-treated macro-
phages, and thus this may be independent of caspase-1 and
caspase-7 pathways.
The role of chitin in the immune system is very controversial
(19, 21, 37, 38). One of the main reasons for this controversy is
that it is difficult to extensively purify chitin (37, 38). Conse-
quently, we cannot exclude the possibility that our chitin does
not contain bioactive contaminants that might contribute to the
observed immune responses. We believe, however, that many
lines of evidence support our model for the role of AMCase
enzymatic activity and chitin cleavage in the physiologically rel-
evant HDM. Further investigation into the relationship between
chitin and immune responses will be needed.
It has been reported that AMCase-deficient mice did not show
dramatic defects after sensitization and challenge with OVA or
HDM plus cockroach allergen (39). These results seem to con-
flict with our observations. Further work will be required to re-
solve this by direct comparison of the two strains. One important
difference, however, is that our AMCase-ED mice still express
AMCase protein that can bind to chitin, although its catalytic
chitinase activity is defective in the lung.
We demonstrated that caspase-7 was activated following
HDM treatment and that the activation of caspase-7 is defective
in Casp1−/− mice as well as AMCase-ED mice. Caspase-7 has
been suggested to be a substrate of the caspase-1 inflammasome
using targeted peptidecentric proteomics (40). In addition, it was
reported that caspase-7 activation after L. pneumophila infection
was dependent on caspase-1 (34). Most recently, it was reported
that caspase-7 is activated by caspase-1 after LPS stimulation
although in that study the activated caspase-7 was shown to
translocate to the nucleus where it played a nuclear function
(33). Altogether, we therefore believe that many published
reports support our finding that caspase-7 activation is de-
pendent on caspase-1 activated during HDM administration.
However, it is still unclear whether caspase-7 activation is due
to cell death, an inflammatory pathway, or other effects that
follow HDM administration.
Regarding the inactivation of IL-33, it was reported that the
biological activity of IL-33 was suppressed through proteolysis by
apoptotic caspases such as caspase-3 and caspase-7 (32). Indeed,
we observed elevated IL-33 in the BAL and enhanced type 2
immune responses in Casp7−/− mice, suggesting a defect in IL-33
inactivation in the absence of caspase-7 although we cannot ex-
clude the possibility of the role of other proteases and caspases
(41–43). Considering the fact that IL-33 is a nuclear protein (31),
it is possible that the activated caspase-7 that is translocated into
the nucleus following activation by caspase-1 may play a role in
IL-33 processing in the nucleus.
In conclusion, by using a newly generated enzymatically dead
AMCase knockin mouse, we found that AMCase plays a crucial
role in the control of type 2 immune responses to HDM. As a
result, mice lacking the enzymatic activity of AMCase showed a
greater immune response. In addition, we have elucidated the
signal cascades that control type 2 immune responses upon
HDM administration and how these signal cascades are mis-
regulated in the absence of AMCase enzymatic activity. Further
investigation of this pathway and its relevance to human asthma
will be of interest.
Materials and Methods
Mice. AMCase-ED mice were generated by the standard ES cell gene-targeting
strategy. AMCase gene fragments were cloned from BAC clone RP23-277I1
(CHORI) containing whole mouse AMCase gene. We introduced GCC at codon
138 in exon 5 of AMCase by in vitro mutagenesis. We also introduced NruI to
identify the mutant allele without any amino acid changes. A 2.5-kb short
fragment and 3.0-kb fragment including a mutated region were ligated into
pEasy-Flox vector. The construct was transfected into C57BL/6 as well as 129 ES
cells. ES cells were cultured with G-418/Neomycin and Gancyclovir to enrich the
recombinant ES cells positively and negatively. A total of 216 B6 ES colonies
and 216 129 ES colonies were harvested and screened by PCR. There were two
correctly targeted ES cells from the C57BL/6 and one from the 129 ES cells. All
three clones were injected into C57BL/6 blastocysts generating chimeric mice.
The chimeric mice were bred, and germline-transmitting knockin mice were
generated. Mice use in these experiments had been backcrossed to C57BL/6Ncr
more than 10 times. Genotyping PCR was performed using the following
primers: F—5′-ACTGGGAGTTTGGAAGAATAG-3′ and R—5′-CTCACACAGTCCT-
TGACAAGGA-3′. The generation of Casp1−/−mice and Casp7−/−mice has been
reported previously (44, 45). Il1r−/− mice were obtained from Jackson Labo-
ratories. Age-matched and sex-matched C57BL/6Ncr (National Cancer Institute
Animal Production Program) mice were used as all WT controls. All animals
were bred and maintained in accordance with the Yale University Institutional
Animal Care and Use Committee protocols.
Mouse Models for Allergic Airway Disease. For administration of HDM, HDM
extract and raw HDM were purchased from Greer Laboratories (Dermato-
phagoides pteronyssinus; B84). Six to 8-wk-old mice were anesthetized with
methoxyflurane (Medical Developments International) and administered
intranasally with PBS or 25 μg of HDM on days 0, 1, and 2. After 2 wk, the
mice were injected intranasally with PBS or 5 μg of HDM on days 14, 15, 16,
and 17. On day 18, the mice were killed and 2 mL of BAL fluid, blood, and
lung were collected. For administration of chitin, chitin from crab shells
(Sigma, C7170, batch no. 065K7026) was suspended in endotoxin-free sterile
PBS (Sigma) and then sequentially passed through 100-μm, 70-μm, and
40-μm cell strainers (BD Biosciences). The fractionated chitin mixture was
washed several times with PBS and with 70% ethanol and suspended in
sterile PBS and then autoclaved. Fifty micrograms of chitin mixture was in-
tranasally administered on days 0, 1, and 2. After 2 wk, 10 μg of chitin
mixture was intranasally administered again on days 14, 15, 16, and 17. On
day 18, the mice were killed and 2 mL of BAL fluid, blood, and lung were
collected. Ovalbumin (Grade V; Sigma) administration was done as described
previously (22).
Chitinase Activity Assay. A chitinase assay kit (Sigma, catalog # CS0908) was
used and followed per manufacturer’s instructions. Briefly, BAL fluids or su-
pernatants from cell cultures are incubated with 4-nitrophenyl N,N′-diacetyl-
β-D-chitobioside at 37 °C and then stopped by adding sodium carbonate so-
lution. The absorption was measured at 405 nm.
RNA Analysis. Total RNA from lung tissue was purified with TRIzol reagent
(Invitrogen) and was reverse-transcribed to cDNA with SuperScript II reverse
transcriptase (Invitrogen). The expression of individual genes was measured
using Taqman probes (Applied Biosystem) in a 7500 Fast Real Time PCR System
(Applied Biosystem).
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Dot Blotting, ELISA, and Western Analysis. Dot blotting for chitin detection
was performed as described previously (46). Antibody pairs for ELISA were
purchased from R&D Systems (IL-1β and IL-33), BD Pharmingen (IL-5, IL-13,
and IgE), or eBioscience (TNFα). Antibodies for Western blotting were pur-
chased from Santa Cruz Biotechnology (caspase-1; clone M-20), Alexis Bio-
chemicals (IL-33; 210–933), or Cell Signaling (caspase-7; #9492). ELISA and
Western blotting were performed as described previously (22).
Limulus Test. The limulus test for endotoxin detection was performed using
Limulus Amebocyte Lysate QCL-1000 (Lonza, catalog # 50–647) per manu-
facturer’s instructions.
T-Cell Restimulation. T-cell restimulation for measuring IL-5 and IL-13 was
performed as described previously (22). Briefly, T cells from lung-draining
lymph nodes were collected from WT and AMCase-ED, Casp1−/−, or Casp7−/−
mice. Cells were restimulated in vitro with or without HDM or ovalbumin
and mitomycin-C (Sigma)–treated splenocytes for 48 h. Supernatants were
analyzed for IL-5 or IL-13.
Histological Analysis. Formalin-fixed sections of lung were prepared and
stained. Hematoxylin and eosin (H&E) staining was done in the Research His-
tology Laboratory of the Department of Pathology at Yale School of Medicine.
Phagocytosis Assay and Flow Cytometry. Chitin was labeled with FITC
(Thermo Scientific) per manufacturer’s instructions. Thioglycollate-eli-
cited peritoneal macrophages were prepared as described previously
(22). The cells were treated with FITC-labeled chitin or FITC-conjugated
latex beads (Cayman Chemical, catalog # 400291) with or without bis-
dionin F (Calbiochem, catalog # 112252), and then flow cytometry was
performed.
Mixed Bone Marrow Chimera. Adoptive transfer of bone marrow was per-
formed as described previously (47). Briefly, bone marrow cells were col-
lected and injected retro-orbitally into sublethally irradiated 5- to 6-wk-old
mice. The recipients were analyzed 10–12 wk after transplantation for
complete chimerism.
Statistical Analysis. An unpaired Student’s t test was performed for statistical
analysis for all studies using GraphPad Prism software. P < 0.05 was con-
sidered statistically significant.
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